metastatic breast cancer中文,metastatic breast cancer的意思,metastatic breast cancer翻译及用法

2026-03-21 20:00 浏览次数 17

metastatic breast cancer

转移性乳腺癌

metastatic breast cancer 例句

英汉例句

  • During the drive he told me that his wife had metastatic breast cancer and was not well, but she insisted upon meeting me.

    在路上他告诉我他的妻子患了乳腺癌并且情形不太好,但是她坚持要见我。

  • Background and purpose: the treatment of advanced metastatic breast cancer is very difficult. The main purpose of the treatment is to alleviate symptoms and prolong quality survival.

    背景与目的:晚期转移性乳腺癌的治疗较为困难,治疗的主要目的为缓解癥状,延长高质量的生存期。

  • Objective To compare the efficacy and toxicity of docetaxel as a single agent for treating metastatic breast cancer with weekly and 3 weekly scheme.

    目的研究单药多烯紫杉醇每周方案及每3周方案治疗转移性乳腺癌的疗效与毒性。

  • Some research shows that only about 25% of newly discovered metastatic breast cancer patients live for 5 years.

    有些研究表明只有大约25%初期的已经转移的乳腺癌患者可以生存5年。

  • Here we show, using a combination of mouse and human cells, that microRNA-10b (miR-10b) is highly expressed in metastatic breast cancer cells and positively regulates cell migration and invasion.

    我们利用向鼠体内的移植人细胞,显示了微小rna - 10 b在转移性乳腺癌细胞有高表达并且调节其转移和侵袭。

  • In prior research involving metastatic breast cancer patients, nab-paclitaxel had produced significantly higher anti-tumor activity than solvent-based paclitaxel.

    前期的研究包括转移性乳腺癌患者,蛋白结合型紫杉醇在抗肿瘤作用比单纯的紫杉醇溶剂要强。

  • Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.

    紫杉醇与S-1作为转移性乳腺癌的一线化疗(选择BC):一项开放标签、非劣效性、随机3期试验。

  • Recurrent or metastatic breast cancer tend to have breast augmentation is contraindicated, after more than three years may be considered medically stable operation.

    乳腺癌术后有复发或转移倾向者禁忌隆乳术,术后三年以上病情稳定的可以考虑手术。

  • To study the efficacy and tolerance of paclitaxel therapy for metastatic breast cancer with adriamycin resistance.

    目的研究紫杉醇治疗阿霉素耐药的晚期乳腺癌的疗效和耐受性。

  • We have developed and characterized a preclinical model for the evaluation of immune-mediated metastatic breast cancer therapies.

    我们开发并描述了一个临床前的模型,用来评估免疫介导转移性乳腺癌疗法。

相关热词